Skip to main content
Virology Journal logoLink to Virology Journal
. 2011 Mar 6;8:102. doi: 10.1186/1743-422X-8-102

Hepatitis B virus in Pakistan: A systematic review of prevalence, risk factors, awareness status and genotypes

Muhammad Ali 1, Muhammad Idrees 1,, Liaqat Ali 1, Abrar Hussain 1, Irshad Ur Rehman 1, Sana Saleem 1, Samia Afzal 1, Sadia Butt 1
PMCID: PMC3058090  PMID: 21375760

Abstract

In Pakistan, there are estimated 7-9 million carriers of hepatitis B virus (HBV) with a carrier rate of 3-5%. This article reviews the available literature about the prevalence, risk factors, awareness status and genotypes of the HBV in Pakistan by using key words; HBV prevalence, risk factors, awareness status and genotypes in Pakistani population in PubMed, PakMediNet, Directory of Open Access Journals (DOAJ) and Google Scholar. One hundred and six different studies published from 1998 to 2010 were included in this study. Weighted mean and standard deviation were determined for each population group. The percentage of hepatitis B virus infection in general population was 4.3318% ± 1.644%, healthy blood donors (3.93% ± 1.58%), military recruits (4.276% ± 1.646%), healthcare persons (3.25% ± 1.202%), pregnant women (5.872% ± 4.984), prisoners (5.75% ± 0.212%), surgical patients (7.397% ± 2.012%), patients with cirrhosis (28.87% ± 11.90%), patients with HCC (22% ± 2.645%), patients with hepatitis (15.896% ± 14.824%), patients with liver diseases (27.54% ± 6.385%), multiple transfused patients (6.223% ± 2.121%), opthalmic patients (3.89% ± 1.004%) and users of injectable drugs (14.95% ± 10.536%). Genotype D (63.71%) is the most prevalent genotype in Pakistani population. Mass vaccination and awareness programs should be initiated on urgent basis especially in populations with HBV infection rates of more than 5%.

Introduction

Hepatitis B virus (HBV) infection is a major global health problem [1-3], especially in Asia, Africa, southern Europe and Latin America [4]. About 2 billion people are infected with HBV worldwide [2,4,5], and 400 million among them are suffering from chronic HBV infection [6]. Pakistan is highly endemic with HBV [7] with nine million people infected with HBV [8] and its infection rate is on a steady rise [9]. The reason may be the lack of proper health facilities, poor economical status and less public awareness about the transmission of major communicable diseases including HBV, HCV and HIV [6].

The clinical course and sequel of chronic hepatitis vary among individuals. Infection with HBV leads to a wide spectrum of clinical presentations, ranging from asymptomatic carrier state to acute self-limiting infection or fulminant hepatic failure, chronic hepatitis with progression to cirrhosis, and hepatocellular carcinoma (HCC) [2].

Studies are too limited to give a clear picture of the prevalence of HBV at the National level, especially among otherwise healthy individuals. Most previous studies targeted different small groups of individuals with some clinical indications therefore; these do not accurately reflect the overall prevalence in Pakistan [7,8]. The present article briefly presents the prevalence, risk factors associated with HBV transmission, awareness status and HBV genotypes prevalent in Pakistani population.

Literature Search and inclusion criteria

Articles were searched in PubMed, PakMediNet, Directory of Open Access Journals (DOAJ) and Google Scholar by using keywords; Hepatitis B virus in Pakistan, Prevalence of HBV in Pakistan, HBV in Blood donors, Hepatitis B virus in general population, HBV in Pakistani healthcare workers, HBV in surgical patients, HBV infection in women and children, HBV infection in prisoners, HBV in diseased population in Pakistan, HBV in injection drug users, epidemiology of HBV in Pakistan, HBV genotypes in Pakistan and awareness about HBV in Pakistani population. Two hundreds and twenty nine different studies (articles/repots) were obtained from the literature search, out of which 106 published from 1998 to 2010 were included in the present review. Studies full filling the following criteria were included: 1) Samples were collected from Pakistani individuals. 2) An obvious description of the methods of detection of HBV infection and genotyping. 3) Information about the number of individuals studied and their residing area were reported. 4) Studies reporting risk factors and awareness status in Pakistani population were included to discuss the HBV prevalence in different population groups.

Analysis

Studies showing percent prevalence of HBV infection in different population are shown in table 1, 2, 3 and 4, while table 5 shows the percentage of different genotypes prevalent in Pakistan. The percent prevalence in the different population groups are presented in mean ± standard deviation (with 95% confidence interval).

Table 1.

Prevalence of HBV in general population, young recruits and prisoners.

Population type Region Methods Population size HBV (%) HBV marker Reference
General population Lahore ELISA 992 8.06% HBsAg Nafees et al. [10] 2009
Larkana ICT, ELISA 200 4.8% HBsAg Shaikh et al. [11] 2009
Lahore ICT 203 2.46 HBsAg Tanveer et al. [12] 2008
Karachi ICT, ELISA. 4000 4.5% HBsAg Noorali et al. [7] 2008
Southern Punjab ICT/ELISA 1821 5.9% HBsAg Mirza et al. [13] 2007
Karachi ICT, ELISA and PCR. 3820 4.5% HBsAg & DNA Hakim et al. [8] 2008
Islamabad AxSym HBsAg, CORE& AUSAB MEIA 1300 4% HBsAg, anti HBs, anti HBc Alam et al. [6] 2007
Central Punjab ICT, ELISA 2038 4.83% HBsAg Alam et al. [14] 2006
Rawalpindi ELISA 665 3% HBsAg Farooq et al. [15] 2005
Lahore ICT 757 2.6% HBsAg Amin et al. [16] 2004
Karachi ICT, ELISA 200 3% HBsAg Qasmi et al. [17] 2000
Recruitments Rural Areas of Pakistan ICT, ELISA 3320 4.5% HBsAg Azam et al. [18] 2009
Interior Sindh ICT, ELISA 5237 7.39% HBsAg Malik et al. [19] 2008
Recruits from all over Pakistan ICT, ELISA 2558 2.8% HBsAg Sherif & Tariq, [20] 2006
Mardan ICT, ELISA 15550 3.24% HBsAg Mirza et al. [21] 2006
All areas of Pakistan ICT, ELISA 4552 4.2% HBsAg Hussain et al. [22]2005
All areas of Pakistan ICT, ELISA 5371 3.53% HBsAg Ali et al. [23] 2002
Prisoners Karachi ELISA 365 5.9% HBs Ag Kazi et al. [24] 2010
Bahawalpur ICT, ELISA 2086 5.6% HBs Ag Fayyaz et al.[25] 2006

ELISA: Enzume linked immunosorbant assay; HBsAg: hepatitis B surface antigen; ICT: Immuno-chromatographic Test, MEIA: Microparticle Enzyme Immunoassay, HBsAg: hepatitis B surface antigen

Table 2.

Percent prevalence rates of HBV in Healthy Blood donors.

Population type Region Methods Population size HBV positive (%) HBV marker Reference
Healthy Blood Donors Kurram Agency ICT 1300 5.07% HBsAg Bangash et al. [26] 2009
Interior
Sindh
ICT 5345 6.2% HBsAg Mujeeb & Pearce, [27] 2008
Karachi ICT 11459 1.71% HBsAg Nazar et al. [28] 2008
Karachi ICT 688 4.50% HBsAg Azam et al. [29] 2007
Northern areas ICT 8949 3.66% HBsAg Alam & Naeem, [30] 2007
Karachi ICT 21,125 3.3% HBsAg Mujeeb & Pearce, [31] 2007
District Thatta ICT 310 5.81% HBsAg Ishaq et al. [32] 2007
Southern Punjab ICT, ELISA 27938 2.69% HBsAg Khan et al. [33] 2006
Lahore ICT 18216 3.36% HBsAg Sirhindi et al. [34] 2005
Karachi ELISA 351309 2.0% HBsAg Akhtar et al. [35] 2005
Peshawar/
KPK
MEIA 4000 1.9% HBsAg Ahmad et al. [36] 2004
Rawalpindi ICT 580 5.86% HBsAg Mumtaz et al. [37] 2002
Northern Pakistan ELISA 103858 3.3% HBsAg Khattak et al. [38] 2002
Bahawalpur LAT, ICT 345 5.64% HBsAg Fayyaz et al. [39] 2002

LAT: Latex agglutination test

Table 3.

Percent prevalence rates of HBV infection in Healthcare workers, pregnant women and pediatric population.

Population type Region Methods Population size HBV positive (%) HBV marker Reference
Health Care Personals Abbottabad ELISA 125 2.4% HBsAg Sarwar et al. [41] 2008
Muzaffarabad RPHA, ELISA 199 4.1% HBsAg Naz et al. [42] 2002
Pregnant women Karachi ICT 2592 0.34% HBsAg Sheikh, [43] 2009
Swat ICT, ELISA 5607 3.98% HBsAg Khattak et al. [44] 2009
Karachi EIA 5902 4.6% HBsAg Sami et al. [45] 2009
Lahore ICT, ELISA 2439 2.2% HBsAg Batool et al. [46] 2008
Bahawalpur ICT, ELISA 300 12.3% HBsAG, HBeAG, HBcAB, HBsAB, Ahmad et al. [47] 2007
Karachi ICT, ELISA 25,482 1.57% HBs Ag Ali & Memon, [48] 2007
Hyderabad ICT, ELISA 103 12.6% HBsAg Yousfani et al. [49] 2006
Rahim Yar Khan ELISA 450 12.0% HBsAg Hakeem et al. [50] 2006
Karachi ICT, ELISA 245 3.26% HBsAg Mehnaz et al. [51] 2002
Children Karachi ELISA 3533 1.8% HBsAg Jafri et al. [52] 2006
Lahore RPHA, ELISA 392 2.04%. HBsAg Khan et al. [53] 1998

EIA: Enzyme Immunoassay, RPHA: Reverse Passive Hemagglutination Technique

Table 4.

Percent prevalence of HBV infection in patients of different diseases in Pakistan.

Population type Region Methods Population size HBV positive(%) HBV marker Reference
Surgical patients Karachi EIA 496 5.0% HBsAg Moosa et al. [57] 2009
Jacobabad Sindh ICT 150 9.33% HBsAg Daudpota & Soomro, [58] 2008
Karachi ELISA 387 6.5% HBsAg Masood et al. [59] 2005
Karachi Latex method, ELISA 411 8.76% HBsAg Shirazi et al. [60] 2004
Patients with cirrhosis Saidu Sharif, Swat ELISA 110 21.81% HBsAg Khan et al. [62] 2009
Dera Ismail Khan ICT 60 46.67% HBsAg Mashud et al. [63] 2004
Lahore ICT, ELISA 94 23% HBsAg, anti-HBcIgG, anti-HBs, and HBeAg Khan et al. [64] 2002
Lahore ELISA 50 24% HBsAg Hussain et al. [65] 1998
Patients with Hepatocellular carcinoma (HCC) Hyderabad ELISA 200 21.0% HBsAg Ansari et al. [66] 2009
Rawalpindi ICT, ELISA 44 25% anti-HBsAg, anti-HBcAb antiHBeAb Mumtaz et al. [67] 2001
Lahore ELISA 30 20% HBsAg Kausar et al. [68] 1998
Patients with hepatitis Rawalpindi ICT 264 9.8% HBsAg Mumtaz & Aftab [69] 2005
Hyderabad/Jamshoro ELISA 100 41% anti-HBs
anti-HBc
Almani et al. [70] 2002
Islamabad ELISA 2574 15% HBsAg Tanwani & Ahmad [71] 2000
Karachi MEIA-Abbott 1225 2% HBsAg Mahmood [72] 2000
Rawalpindi RPHA or ELISA 4315 11.68% HBsAg Hussain &
Ahmed [73] 1998
Patients of Liver disease Karachi ICT, ELISA, PCR 5193 32.6% HBsAg Ahmed et al. [74] 2010
Peshawar ICT, ELISA and PCR. 181 18.23% HBs Ag or DNA Khan [75] 2006
Faisalabad ELISA 100 29% HBsAg Bilal et al. [76] 2006
Hazara Division ICT 893 30.35% HBsAg Khan and Rizvi [77] 2003
MTP (Thalassemic & Hemophiliac Children) Islamabad ICT, ELISA 251 3.9% HBsAg Burki et al. [79] 2009
Peshawar ELISA 250 8.4% HBsAg Shah et al. [80] 2005
Peshawar ELISA 80 7.591 HBsAg Mohammad et al. [81] 2003
Peshawar ELISA 40 5% HBsAg Hussain et al. [82] 2003
Ophthalmic Patients Jamshoro/Hyderabad ICT 931 4.6% HBsAg Junejo et al. [88] 2009
Dera Ismail Khan ICT, ELISA 1130 3.18% HBsAg Ahmad et al. [89] 2006
IDU Peshawar ELISA 250 22.4% HBsAg Alam et al. [86] 2007b
Karachi ELISA 161 7.5% HBsAg Altaf et al. [87] 2007

MTP: Multi-transfused Population, IDU: Injecting drug Users

Table 5.

Summaries of the studies conducted on prevalence of HBV genotypes in Pakistan.

Authors Region Patients (n) Genotype A Genotype B Genotype C Genotype D Genotype E Genotype F Untypable Mixed
Awan et al. [96] 2010 All areas of Pakistan 300 43 (14.33%) 54 (18%) 83 (27.66%) 39 (13%) 2 (0.66%) 4 (1.33%) 31 (10.33%) 44 (14.66%)
Ahmed et al. [97] 2009 Punjab and Sindh 236 2 (0.85%) - 14
(5.93%)
220 (93.22%) - - - -
Baig et al. [98] 2009 Karachi 315 65 (20%) - - 219 (70%) - - - 31 (10%)
Noorali et al. [7] 2008 Karachi 180 - - - 150 (83.33%) - - - 30 (16.66%)
Hakim et al. [8] 2008 Karachi 180 - - - 151 (83.89%) - - - 29 (16.11%)
*Alam et al. [99] 2007 Patients from All four Provinces 110 5 (4.55) 27(24.54%) - 66 (60%) - - 9 (8.18%) 3 (2.73%)
Baig et al. [100] 2007 Karachi 295 60 (20.34%) - - 208 (70.51%) - - - 27 (9.15%)
Alam et al. [86] 2007 KPK 56 15 (8.92%) - - 35 (62.5%) - - - 16 (28.57%)
Abbas et al. [101] 2006 Karachi 109 - - - 109 (100%) - - - -
Idrees et al. [1] 2004 Patients from All four Provinces 112 24 (21.42%) 20 (17.86%) 46 (41.07%) 9 (8.03%) - - 5 (4.46%) 8 (7.14%)
Total 1893 190 (10.03%) 101 (5.335%) 143 (7.55%) 1206 (63.71%) 2 (0.105%) 4 (0.21%) 45 (2.377%) 188 (9.931%)

KPK: Khyber Pakhtunkhwa Province

*The percentage values are different in the original manuscript as the authors considered the untypable samples as negative for genotype.

Formula used for determination of mean prevalence in each population group

μ=(Σ xi)/N

Formula used for determination of standard deviation (SD) in each population group

σ=1Ni=1N(xiμ)2.

Where "x" is the percent HBV prevalence reported in each study and "N" is the total number of studies in the population groups.

HBV prevalence in various population groups

General population (healthy population)

Eleven different studies reported the percent prevalence rates of hepatitis B virus of in general population as 4.3318% ± 1.644% (2.46%-8.06%) [6-8,10-17], while six different studies involving healthy recruits showed the prevalence rate of 4.276% ± 1.646%. [18-23]. HBV prevalence of 5.75% ± 0.212% was observed in prisoners [24,25]. Fourteen different studies showed the prevalence rate of 3.93% ± 1.58% in healthy blood donors in Pakistan [26-39]. HBV prevalence of 9.0% has been reported in professional blood donors [40]. Two different studies showed the prevalence of HBV in health care workers as 3.25% ± 1.202% [41,42]. Nine studies showed the HBV prevalence of 5.872% ± 4.984% in pregnant women [43-51], while two different studies demonstrated 1.92% ± 0.169% prevalence in children [52,53]. A very high frequency of ≥12% HBV infection in pregnant females has been reported in Bahawalpur, Hyderabad and Rahim Yar Khan regions [47,49,50]. Up to 21% of the children born of HBV infected females were infected [47], while Kazmi et al. [54] showed a high prevalence of 90% in children born of HBV positive mothers. Quddus et al. [55] showed HBV prevalence of 8.3% in Afghan refuges residing in Pakistan. Anwar et al. [56] showed a high prevalence rate of HBV that was 11.65% in female prostitutes in Lahore, Pakistan. Frequency of viral hepatitis in blood donors is higher in Bahawalpur as compared to rest of the world [33].

These studies show that Southern Punjab, Interior Sindh, District Tatta, Kurrum agency and some areas of Lahore have very high HBV prevalence of >5%, hence mass vaccination and awareness programs in these areas on urgent basis is suggested.

Surgical patients

Four different studies showed 7.397% ± 2.012% HBV prevalence rates in patients undergoing surgery [57-60]. The lack of routine serological screening in Pakistani hospitals prior to surgery is one of the factors responsible for increased disease transmission [59]. It is recommended that every case undergoing surgery should be screened for hepatitis B and C virus infections [61].

Patients with hepatitis, liver diseases, HCC and cirrhosis

Four different studies showed the percent HBV prevalence of 28.87% ± 11.90% in patients with cirrhosis [62-65] while 22% ± 2.645% HBV prevalence was shown by three different studies in patients with HCC [66-68]. Five studies in patients with hepatitis showed the percent prevalence of 15.896% ± 14.824% [69-73] while four different studies in patients with different liver diseases showed the prevalence of HBV as 27.54% ± 6.385% [74-77].

Muti-tranfused population (thalassemic and hemophilic patients)

Thalassemic and hemophilic patients require life-long blood transfusions, so it is necessary to obtain screened blood from a reputable source, because the multitransfused population is more prone to blood-borne pathogens [78]. Four different reports showed percent HBV infection of 6.223% ± 2.121% in multi-tranfused population [79-82].

Intravenous drug users (IDU)

Pakistan is estimated to have 4 to 4.8 million drug users with 180,000 IDUs [83]. Strathdee et al. [84] observed significant increase in needle sharing in IDUs since 2001. Among them Afghan refugees have higher levels of needle sharing as compared to the local IDUs [85]. Two different reports showed a very high HBV prevalence of 14.95% ± 10.536% in injection drug users [86,87].

Patients with other diseases

Two different reports show the prevalence of HBV in ophthalmic patients to be 3.89% ± 1.004% [88,89], percent prevalence of HBV was 12.4% in patients on hemodialysis [90], 26% in psychiatric patients [91], 10.2% in patients advised for liver function tests [92], 1.5% in patients with dermatoses caused by lichen planus [93] and 2.02% in orthopedics patients [94]. High prevalence among psychiatric patients could be due to razor sharing, facial and armpit shaving from barbers and carelessness during injuries.

Genotypes

Hepatitis B virus exists in eight different genotypes (A-H) and its prevalence differs with differs by geography and ethnicity [95]. Ten different studies (Table 5) conducted at different regions of Pakistan showed that the most prevalent HBV genotype in Pakistan is genotype D with overall prevalence rate of 63.71% followed by genotype A (10.036%), genotype C (7.55%) and genotype B (5.335%) while untypable and mixed genotypes were 2.377% and 9.931%, respectively [1,7,8,87,97-102]. The most detailed study recently conducted by Awan et al. [96] showed that the most emerging genotype in Pakistani population is genotype C with the prevalence rate of 27.66%, which is a bad news as it is more common in cirrhotic patients and is known to be associated with more severe liver diseases. Moreover, Previous studies also shows that genotype D have more severe disease, less responsive to interferon therapy as compared to genotype A and B and have higher HBV DNA levels. This genotype also has specific viral sequence patterns that may predict long-term response to lamivudine treatment [101]. However, further studies are needed to characterize prevalence of different genotypes, their relative severity and treatment response rates in Pakistani population.

Risk factors associated with HBV infection

History of dialysis for more than 2 years is a risk factor for dialysis patients [90]. Major risk factors for mother to infant transmission include increasing maternal age, number of pregnancies, repeated injections and addiction [51]; major risk factors in surgical patients include re-use of contaminated syringes, contaminated surgical instruments and blood products [59]; risk factors in pregnant women (antenatal) include ear and nose prick, history of jaundice among them or with their partner [49], history of blood transfusions, history of injections [46,49], tooth extraction [46]; in prisoners significant risk factors were intravenous drug abuse [24,25], rural origin and shaved by barber [25]; in orthopedic patients common risk factors are previous history of surgery or blood transfusion [94]. Major risk factors for health care workers are dental procedures, needle prick and surgical procedures [41]; most important risk factors for HBV infection in young recruits were sharing of razors, history of intravenous injections, jaundice in the subject and jaundice in family [22]; in children key risk factors were injection in the past, surgical and dental procedures, blood transfusion, accidental cuts at barber shops and umbilical cord cut through unsterilized instruments at home [102]; in thalassaemic children there is a definite risk factor of repeated blood transfusion [79], while main risk factors among the obstetrical and gynecological population were unsafe surgery, injections and inadequately screened blood transfusions [45]. Qureshi et al. [103] compared male patients suffering from chronic hepatitis with healthy people as control and found very strong relationship of the HBV infection with history of dental treatment, surgery and history of taking injections. It is established fact that HBsAg does not cross the placental barrier however; the infection in children/newborns may occur at the time of birth or soon after birth. The infants of HBV positive mothers must be vaccinated soon after birth and HBIG immediately within 24 hours of birth [54]. Relatively low prevalence in the female prostitutes (high risk group) reflects the effect of legal, social and religious constraints in Pakistani society [56]. Many of the Afghan refuges (most of them are children) are rag pickers who collect used syringes and needles dumped outside the hospitals and hence are one of the most vulnerable groups to viral hepatitis in Pakistan [104]. Most of these factors are easily preventable and need awareness in general population and the healthcare workers.

Preventive strategies for HBV infection include healthy blood transfusion services along with safe sex [34], vaccination against HBV [40,103], shaving by barbers needs to be discouraged [103] and better training of healthcare workers [105]. Paid blood donation should be prohibited [85]. All patients needing surgery should be screened for viral hepatitis and there should be separate operation theatres facilities for these patients [94]. In addition reuse of razors in many barber shops that may spread hepatitis in a substantial number of individuals [106] and must be discouraged. Importantly, the most common risk factors and modes of HBV transmission in this country differ in importance in various community groups [23].

In Turkish population, HLA-A24 and Cw1 has been associated with low risk for HBV-related chronic liver disease and HLA- B13, B8, DR7, DR13 and DQ3 were found associated with high risk for chronic HBV infection [107]. However, there is no study that describes cellular or molecular mechanism of HBV infection in Pakistani population.

Awareness about HBV in Pakistani population

Nasim et al. [108] conducted a questioner bases survey in Karachi to assess knowledge about viral hepatitis among college girls and showed that 57% of them do not have information about transmission of hepatitis B virus. In another survey [109] at obstetric and gynecology clinic at Hyderabad showed that most of the women (67.76%) know that HBV is a viral disease, 75.20% responded that it affect liver, 33.88% believed that it could be transmitted by infected blood transfusion, 17.35% believed that it could be transmitted from mother to child, 19.0% mentioned sexual intercourse responsible for HBV infection, while 40.49% and 38.0% mentioned contaminated needles and un-sterilised instruments as a source of HBV infection, respectively. Mengal et al. [110] surveyed nursing students at nursing school, Bolan medical complex hospital, Quetta and reported that only 37.2% of them were completely vaccinated and 25.0% had not been vaccinated for HBV. Chaudhry et al. [111] repoted that 97.4% of the barbers at Islamabad use new blade for every customer but only 38% of them has knowledge about routes of infection of HBV and HCV. In another study, Waheed et al. [112] reported that 39.6% of the barbers at Rawalpindi and Islamabad knew that Hepatitis B and hepatitis C were viral diseases, 90.7% thought that hepatitis could spread by blade sharing, 26.6% knew that it can lead to cancer and 47.8% knew that a vaccine for HBV was available. Ali et al. [113] reported that 78.8% of the rural population of Faisalabad was unaware of viral hepatitis. In another study, Asif et al. [114] reported that only 17.6% of the rural population of Nowshera was aware of the fact that Hepatitis B and C are transmitted by a virus. Talpur et al. [115] stated that there is significant lack of knowledge and poor attitude towards HBV and HCV in surgical patients at Nawabshah area. We suggest aggressive public awareness programs especially in rural areas and people at high risk to decrease the burden of HBV infection in Pakistan.

Conclusions

This article reviews prevalence of HBV in different areas and population groups in Pakistan, along with awareness status, risk factors and genotypes in Pakistani population. Prevalence of HBV infection varies with population residing in different regions of Pakistan. The present literature shows that Afghan refuges in Pakistan, IDUs, professional blood donors, health care professionals, prisoners, multiple transfused patients, patients with HCC, psychiatric patients, general population of some specific areas like Southern Punjab, Interior Sindh, District Tatta, Kurrum agency, Baltistan and some areas of Lahore have very high HBV prevalence of more than 5%, and there is urgent need of mass vaccination and awareness programs. Further studies are needed to characterize HBV prevalent in Pakistan at molecular level. Moreover, both host and viral factors associated with molecular and cellular mechanism of HBV infection in Pakistani population needs to be explored.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

MA and MI conceived the study and designed the inclusion criteria. MA searched the literature and drafted the manuscript. MI, IR and AH critically reviewed the manuscript. IR, SS, SA, SB and LA helped MA in literature search, data extraction and statistical analysis. All the authors read and approved the final manuscript.

Contributor Information

Muhammad Ali, Email: ali_biotech01@yahoo.com.

Muhammad Idrees, Email: idreeskhan96@yahoo.com.

Liaqat Ali, Email: liaqatbiotech@yahoo.com.

Abrar Hussain, Email: abrarbangash176@hotmail.com.

Irshad Ur Rehman, Email: irshad_rehman@yahoo.com.

Sana Saleem, Email: sanacemb@yahoo.com.

Samia Afzal, Email: samiaraza@live.com.

Sadia Butt, Email: sadiasi@yahoo.com.

References

  1. Idrees M, khan S, Riazuddin S. Common genotypes of hepatitis B virus. J Coll Phy Sur Pak. 2004;14:344–7. [PubMed] [Google Scholar]
  2. Zhu R, Zhang H, Yu H, Li H, Ling YQ, Hu XQ, Zhu HG. Hepatitis B virus mutations associated with in situ expression of hepatitis B core antigen, viral load and prognosis in chronic hepatitis B patients. Pathol Res Pract. 2008;204:731–742. doi: 10.1016/j.prp.2008.05.001. [DOI] [PubMed] [Google Scholar]
  3. Ali L, Idrees M, Ali M, Rehman I, Hussain A, Afzal S, Butt S, Saleem S, Munir S, Badar S. An overview of treatment response rates to various anti-viral drugs in Pakistani Hepatitis B Virus infected patients. Virology J. 2011;8:20. doi: 10.1186/1743-422X-8-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Li G, Li W, Guo F, Xuc S, Zhaod N, Chena S, Liu L. A novel real-time PCR assay for determination of viral loads in person infected with hepatitis B virus. J Virol Meth. 2010;165:9–14. doi: 10.1016/j.jviromet.2009.12.009. [DOI] [PubMed] [Google Scholar]
  5. Paraskevis D, Haida C, Tassopoulos N, Raptopoulou M, Tsantoulas D, Papachristou H, Sypsa V, Hatzakis A. Development and assessment of a novel real-time PCR assay for quantitation of HBV DNA. J Virol Meth. 2002;103:201–212. doi: 10.1016/S0166-0934(02)00033-2. [DOI] [PubMed] [Google Scholar]
  6. Alam MM, Zaidi SZ, Malik SA, Naeem A, Shaukat S, Sharif S, Angez M, Khan A, Butt JA. Serology based disease status of Pakistani population infected with Hepatitis B virus. BMC Infect Dis. 2007;7:64. doi: 10.1186/1471-2334-7-64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Noorali S, Hakim ST, McLean D, Kazmi SU, Bagasra O. Prevalence of Hepatitis B virus genotype D in females in Karachi, Pakistan. J Infect Developing Countries. 2008;2:373–378. doi: 10.3855/jidc.200. [DOI] [PubMed] [Google Scholar]
  8. Hakim ST, Kazmi SU, Bagasra O. Seroprevalence of Hepatitis B and C Genotypes Among Young Apparently Healthy Females of Karachi-Pakistan. Libyan J Med. 2008;3:66–70. doi: 10.4176/071123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hepatitis prevention & control program Sindh (chief minister's initiative) 2009. directorate general health services, Hyderabad, Sindh, Pakistan
  10. Nafees M, Farooq M, Jafferi G. Frequency of hepatitis B and C infections in the general population of Lahore, Pakistan. Biomedica. 2009;25:106–11. [Google Scholar]
  11. Shaikh EM, Naz S, Bhatti A, Shaikh MA, Shaikh R, Shaikh WM, Laghari KN. Seroprevalence of hepatitis B & C at shaikh zaid women hospital larkana. Medical channel. 2009;15:161–163. [Google Scholar]
  12. Tanveer A, Batool K, Qureshi AW. Prevalence of hepatitis B and c in university of the Punjab, Quaid-e-azam campus, Lahore. ARPN J Agri Bio Sci. 2008;3:30–32. [Google Scholar]
  13. Mirza IA, Kazmi SMH, Janjua AN. Frequency of hepatitis B surface antigen and anti-HCV in young adults - experience in southern Punjab. J Coll Phy Sur Pak. 2007;17:114–115. [PubMed] [Google Scholar]
  14. Alam M, Tariq WZ, Akram S, Qureshi TZ. Frequency of hepatitis B and C in central Punjab. Pak J Pathol. 2006;17(4):140–141. [Google Scholar]
  15. Farooq MA, Iqbal MA, Tariq WZ, Hussain AB, Ghani I. Prevalence of hepatitis B and C in a healthy cohort. Pak J Pathol. 2005;16:42–46. [Google Scholar]
  16. Amin J, Yousuf H, Mumtaz A, Iqbal M, Ahmed R, Adhami SZ, Malik K. Prevalence of hepatitis B surface antigen and anti hepatitis C virus among general population in Lahore. Prof Med J. 2004;11:334–7. [Google Scholar]
  17. Qasmi SA, Aqeel S, Ahmed M, Alam SI, Ahmad A. Detection of hepatitis B viruses in normal individuals of Karachi. J Coll Phy Sur Pak. 2000;10:467–9. [Google Scholar]
  18. Azam N, Mufti K, Zafar N. Frequency of hepatitis b & c in young male recruits from rural Pakistan. Pak Arm Forc Med J. 2009;2:59–64. [Google Scholar]
  19. Malik N, Butt T, Mansoor N, Khan TG, Akbar MS, Asl M. Percentage of hepatitis B and C among young adult males from interior Sindh. Pak Arm Forc Med J. 2008;58:260–266. [Google Scholar]
  20. Sherif T, Tariq WZ. Seroprevalence of hepatitis B and C in healthy adult male recruits. Pak J Pathol. 2006;17:147–150. [Google Scholar]
  21. Mirza IA, Mirza SH, Irfan S, Siddiqi R, Tariq WZ, Janjua AN. Seroprevalence of Hepatitis B and C in young adults seeking recruitment in armed forces. Pak Arm Forc Med J. 2006;56:192–197. [Google Scholar]
  22. Hussain AB, Hashim R, Rehman K. Hepatitis B surface antigen. Prof Med J. 2005;12:213–217. [Google Scholar]
  23. Ali N, Khattak J, Anwar M, Tariq WZ, Nadeem M, Irfan M, Asif M, Hussain AB. Prevalence of hepatitis B surface antigen and hepatitis C antibodies in young healthy adults. Pak J Pathol. 2002;13:3–6. [Google Scholar]
  24. Kazi AM, Shah SA, Jenkins CA, Shepherd BE, Vermund SH. Risk factors and prevalence of tuberculosis, human immunodeficiency virus, syphilis, hepatitis B virus, and hepatitis C virus among prisoners in Pakistan. Int J Infect Dis. 2010;14S:e60–e66. doi: 10.1016/j.ijid.2009.11.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Fayyaz M, Qazi MA, Ishaq M, Chaudhary G M, Bukhari MH. Frequency of hepatitis B and C seropositivity in prisoners. Biomedica. 2006;22:55–8. [Google Scholar]
  26. Bangash MH, Bangash TH, Alam S. Prevalance of hepatitis B and hepatatis C among healthy blood donors at Kurram agency. J Postgrad Med Inst. 2009;23:140–5. [Google Scholar]
  27. Mujeeb SA, Pearce MS. Temporal trends in hepatitis B and C infection in family blood donors from interior Sindh, Pakistan. BMC Infect Dis. 2008;8:43. doi: 10.1186/1471-2334-8-43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Nazar H, Nadia N, Shazia N, Zulfiqar A, Farhat A. Prevalence of Hepatitis B and Hepatitis C in blood donors of Karachi. Biomedica. 2008;24:116–117. [Google Scholar]
  29. Azam M, Jamal N, Imtiaz F, Haque Z, Ayoob Z. Blood donor screening for hepatitis and HIV. J Dow Uni Health Sci. 2007;1:82–83. [Google Scholar]
  30. Alam M, Naeem MA. Frequency of hepatitis B surface antigen and anti-hepatitis C antibodies in apparently healthy blood donors in Northern areas. Pak J Pathol. 2007;18:11–14. [Google Scholar]
  31. Mujeeb SA, Pearce MS. Seroprevalence and determinants of risk of Hepatitis B and C viral infections in blood donors: A cross sectional analytic study. J Infect Developing Countries. 2007;1:17–24. [Google Scholar]
  32. Ishaq M, Ali SS, Karim N, Umrani NI, Hassan N. Frequency of hepatitis B and C virus among the healthy volunteer blood donors at Taulka hospital Sujjawal, District Thatta, Sindh. Ann Abbasi Shaheed Hosp Karachi Med Dent Coll. 2007;12:97–101. [Google Scholar]
  33. Khan MA, Chaudhary GM, Fayyaz M, Qazi MA, Ahmed G. Hepatitis B, C & HIV; seroprevalence of infection in blood donors. Professional Med J. 2006;13:632–636. [Google Scholar]
  34. Sirhindi GA, Khan AA, Alam SS, Ghori MA, Rehman R, Soomro NA, Ahmed Z, Naeem MS, Shah WH, Hussain A, Chohan RA. Frequency of Hepatitis B, C and human immunodeficiency virus in blood donors at Shaikh Zayed hospital, Lahore. Proceeding Shaikh Zayed Postgrad Med Inst. 2005;19:33–6. [Google Scholar]
  35. Akhtar S, Younus M, Adil S, Hassan F, Jafri SH. Epidemiologic study of chronic hepatitis B virus infection in malevolunteer blood donors in Karachi, Pakistan. BMC Gastroenterol. 2005;5:26. doi: 10.1186/1471-230X-5-26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Ahmad J, Taj AS, Rahim A, Shah A, Rehman M. Frequency of hepatitis B and hepatitis C in healthy blood donors of NWFP: A single center experience. J Postgrad Med Inst. 2004;18:343–52. [Google Scholar]
  37. Mumtaz S, Rehman M, Muzaffar M, Hassan M, Iqbal W. Frequency of seropositive blood donors for hepatitis B, C and HIV viruses in railway hospital Rawalpindi. Pak J Med Res. 2002;41:51–3. [Google Scholar]
  38. Khattak MF, Salamat N, Bhatti FA, Qureshi TZ. Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan. J Pak Med Assoc. 2002;52:398–402. [PubMed] [Google Scholar]
  39. Fayyaz KM, Ali S, Khan AA, Shafique M, Khan MA, Majeed S, Butt AS. Hepatitis B carriers; diagnosis among volunteer blood donor students at Quaid-i-Azam medical college Bahawalpur. Professional Med J. 2002;9:186–90. [Google Scholar]
  40. Ahmed M. Hepatitis B surface antigen study in professional and volunteer blood donors. Ann Abbasi Shaheed Hosp Karachi Med Dent Coll. 2001;6:304–306. [Google Scholar]
  41. Sarwar J, Gul N, Idris M, Rehman A, Farid J, Adeel MY. Seroprevalence of hepatitis B and hepatitis C in healthcare workers in Abbottabad. J Ayub Med Coll Abottabad. 2008;20:27–29. [PubMed] [Google Scholar]
  42. Naz S, Ahmad M, Agha H. Prevalence of hepatitis 'B' among hospital personnel in Combined Military Hospital (CMH) Muzaffarabad. Int J Agri Biol. 2002;4:227–230. [Google Scholar]
  43. Sheikh SM. Hepatitis B and C: value of universal antenatal screening. J Coll Phy Sur Pak. 2009;19:179–82. [PubMed] [Google Scholar]
  44. Khattak ST, Marwat MA, Khattak I, Khan TM, Naheed T. Comparison of frequency of hepatitis B and hepatitis C in pregnant women in urban and rural area of district Swat. J Ayub Med Coll Abottabad. 2009;21:12–5. [PubMed] [Google Scholar]
  45. Sami S, Korejo R, Bhutta SZ. Prevalence of hepatitis B and C: A Jinnah postgraduate medical centre experience. J Obstetrics and Gynecology Res. 2009;35:533–538. doi: 10.1111/j.1447-0756.2008.00991.x. [DOI] [PubMed] [Google Scholar]
  46. Batool A, Bano KA, Khan MI, Hussain R. Antenatal screening of women for hepatitis B and C in an out-patient department. J Dow Uni Health Sci. 2008;2:32–5. [Google Scholar]
  47. Ahmad A, Khichi GQ, Rehman A. Hepatitis B markers. Professional Med J. 2007;1:307–311. [Google Scholar]
  48. Ali HS, M Memon A. Prevalence of hepatitis B infection in pregnant women in a tertiary care hospital. J Infect Dis Pak. 2007;16:35–38. [Google Scholar]
  49. Yousfani S, Mumtaz F, Memon A, Memon MA, Sikandar R. Antenatal screening for hepatitis B and C virus carrier state at a university hospital. JLUMHS. 2006;5:24–27. [Google Scholar]
  50. Hakeem A, M Khan S, Abdullah M, Rehman A, Hashmi MI. Prevalence of HbsAg & Anti HCV in pregnant ladies attending antenatal clinic at Sheikh Zayed Medical Complex, Rahim Yar Khan. Esculapio. 2006;2:6–8. [Google Scholar]
  51. Mehnaz A, Hashmi H, Syed S, Kulsoom. Hepatitis B markers in mothers and its transmission in newborn. J Coll Phy Sur Pak. 2002;12:240–2. [Google Scholar]
  52. Jafri W, Jafri N, Yakoob J, Islam M, Tirmizi SF, Jafar T, Akhtar S, Hamid S, Shah HA, Nizami SQ. Hepatitis B and C: prevalence and risk factors associated with seropositivity among children in Karachi, Pakistan. BMC Infect Dis. 2006;6:10. doi: 10.1186/1471-2334-6-101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Khan MA, Ali AS, Hassan Z, Mir F, Haque S. Seroprevalence of hepatitis B in children. Pak Paed J. 1998;22:75–77. [Google Scholar]
  54. Kazmi K, Ghafoor A, Qureshi WA. Mother-infant transmission of hepatitis B in Pakistan. Pak J Med Res. 2003;42:152–6. [Google Scholar]
  55. Quddus A, Luby S, Jamal Z, Jafar T. Prevalence of hepatitis B among Afghan refugees living in Balochistan, Pakistan. Int J Infect Dis. 2006;10:242–247. doi: 10.1016/j.ijid.2005.04.007. [DOI] [PubMed] [Google Scholar]
  56. Anwar MS, Jaffery G, Rasheed A. Serological screening of female prostitutes for anti-HIV and hepatitis B surface antigen. Pak J Health. 1998;35:69–73. [Google Scholar]
  57. Moosa FA, Shaikh BA, Choudhry MS, Zuberi BF, Khan FW, Sultan N. Frequency of hepatitis B and C in pre-operative patients for elective surgery. JLUMHS. 2009;8:150–152. [Google Scholar]
  58. Daudpota AQ, Soomro AW. Sero prevalence of hepatitis B and C in surgical patients. Pak J Med Sci. 2008;24:483–484. [Google Scholar]
  59. Masood Z, Jawaid M, Khan RA, Rehman S. Screening for hepatitis B & C: A routine preoperative investigation. Pak J Med Sci. 2005;21:455–9. [Google Scholar]
  60. Shirazi B, Jaffery AH, Kishwar M, Shamim MS. Screening for hepatitis B & C in surgical patients. J Coll Phy Sur Pak. 2004;9:10–3. [Google Scholar]
  61. Chaudhary IA, Khan SA, Samiullah. Should we do hepatitis B and C screening on each patient before surgery: Analysis of 142 cases. Pak J Med Sci. 2005;21:278–80. [Google Scholar]
  62. Khan P, Ahmad A, Muhammad N, Khan TM, Ahmad B. Screening of 110 cirrhotic patients for hepatitis B and C at Saidu teaching hospital Saidu sharif Swat. J Ayub Med Coll Abbottabad. 2009;21:119–121. [PubMed] [Google Scholar]
  63. Mashud I, Khan H, Khattak AM. Relative frequency of hepatitis B and C viruses in patients with hepatic cirrhosis at DHQ teaching hospital DI Khan. J Ayub Med Coll Abottabad. 2004;16:32–4. [PubMed] [Google Scholar]
  64. Khan AA, Rehman K, Haider Z, Shafqat F. Seromarkers of hepatitis B and C in patients with cirrhosis. J Coll Phy Sur Pak. 2002;12:105–7. [Google Scholar]
  65. Hussain I, Nasrullah M, Shah AA. Prevalence of hepatitis B and C viral infections in liver cirrhosis in Pakistan. Pak J Gastroenterol. 1998;12:7–11. [Google Scholar]
  66. Ansari S, Memon MS, Devrajani BR. Frequency of hepatitis B and hepatitis C in patients with hepatocellular carcinoma at Hyderabad. JLUMHS. 2009;8:109–12. [Google Scholar]
  67. Mumtaz MS, Iqbal R, Umar M, Khar B, Mumtaz MO, Anwar F, Zulfiqar S, Ejaz S, Hanif S, Khan MA, Mazhar S, Abassi S. Sero-prevalence of hepatitis B and C viruses in hepatocellular carcinoma. J Rawal Med Coll. 2001;5:78–80. [Google Scholar]
  68. Kausar S, Shafqat F, Shafi F, Khan AA. The association of hepatocellular carcinoma with hepatitis B and C viruses. Pak J Gastroenterol. 1998;12:1–2. [Google Scholar]
  69. Mumtaz S, Aftab I. Seromarkers of hepatitis B & C viruses observed in symptomatic cases of teaching hospital of IIMC (Railway Hospital) Rawalpindi. Ann Pak Inst Med Sci. 2005;1:242–4. [Google Scholar]
  70. Almani SA, Memon AS, Qureshi AF, Memon NM. Hepatitis viral status in Sindh. Professional Med J. 2002;9:36–43. [Google Scholar]
  71. Tanwani AK, Ahmad N. Prevalence of hepatitis B surface antigen and anti-hepatitis C virus in laboratory based data at Islamabad. J Surg. 2000;20:25–29. [Google Scholar]
  72. Mahmood A. Hepatitis B Virus: Prevalence in Karachi. J Coll Phy Sur Pak. 2000;10:107–108. [Google Scholar]
  73. Hussain T, Ahmed SZ. Acute hepatitis B - Serological confirmation. Pak Armed Forces Med J. 1998;48:102–5. [Google Scholar]
  74. Ahmed W, Arif A, Alam SE, Qureshi H. Changing trend of viral hepatitis-"A twenty one year report from Pakistan medical research council research centre, Jinnah postgraduate medical centre, Karachi". J Pak Med Assoc. 2010;61:86–89. [PubMed] [Google Scholar]
  75. Khan H. Liver disease pattern in a tertiary care hospital of Peshawar, Pakistan. Hepatitis Monthly. 2006;6:85–86. [Google Scholar]
  76. Bilal A, Qureshi FS, Omar Z, Khalid G. Frequency of hepatitis B and C virus in patients with decompensated cirrhosis of liver in Faisalabad. Pak J Gastroenterol. 2006;20:43–48. [Google Scholar]
  77. Khan TS, Rizvi F. Hepatitis B seropositivity among chronic liver disease patients in Hazara Division Pakistan. J Ayub Med Coll Abottabad. 2003;15:54–5. [PubMed] [Google Scholar]
  78. Waheed Y, Shafi T, Safi SZ, Qadri I. Hepatitis C virus in Pakistan: A systematic review of prevalence, genotypes and risk factors. World J Gastroenterol. 2009;15:5647–5653. doi: 10.3748/wjg.15.5647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Burki MF, Hassan M, Ali L, Wadood MZ. Frequency of hepatitis B virus in regularly blood transfused beta thalassemia major patients. Pak Paed J. 2009;33:153–156. [Google Scholar]
  80. Shah MA, Khan MT, Ulla Z, Ashfaq Y. Prevalence of hepatitis B and hepatitis C virus infection in multi-transfused thalassemia major patients in North West Frontier Province. Pak J Med Sci. 2005;21:281–3. [Google Scholar]
  81. Mohammad J, Hussain M, Khan MA. Frequency of hepatitis B and hepatitis C infection in thalassemic children. Pak Paed J. 2003;27:161–4. [Google Scholar]
  82. Hussain M, Khan MA, Mohammad J, Jan A. Frequency of hepatitis B and C in hemophiliac children. Pak Paed J. 2003;27:157–60. [Google Scholar]
  83. UNESCAP. Taking it to the streets: A harm reduction program for Pakistani drug users (Nai Zindagi, Pakistan) HIV/AIDS Prevention, Care and Support: Stories from the Community; 2010. http://www.unescap.org/esid/hds/pubs/2249/p1e.pdf [Google Scholar]
  84. Strathdee SA, Zafar T, Brahmbhatt H, Baksh A, Hassan S. Rise in needle sharing among injection drug users in Pakistan during the Afghanistan war. Drug Alcohol Depend. 2003;71:17–24. doi: 10.1016/S0376-8716(03)00072-3. [DOI] [PubMed] [Google Scholar]
  85. Ahmed MA, Zafar T, Brahmbhatt H, Imam G, Ul Hassan S, Bareta JC, Strathdee SA. HIV/AIDS risk behaviors and correlates of injection drug use among drug users in Pakistan. J Urban Health. 2003;80:321–329. doi: 10.1093/jurban/jtg034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Alam MM, Zaidi SZ, Shaukat S, Sharif S, Angez M, Naeem A, Saleha S, Butt JA, Malik SA. Common genotypes of hepatitis B virus prevalent in injecting drug abusers (addicts) of North West Frontier Province of Pakistan. Virol J. 2007;4:63. doi: 10.1186/1743-422X-4-63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Altaf A, Shah SA, Zaidi NA, Memon A, Rehman N, Wray N. High risk behaviors of injection drug users registered with harm reduction programme in Karachi, Pakistan. Harm Reduct J. 2007;4:7. doi: 10.1186/1477-7517-4-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Junejo SA, Khan NA, Lodhi AA. Prevalence of hepatitis B and C infection in patients admitted at tertiary eye care centre: A hospital based study. Pak J Med Sci. 2009;25:597–600. [Google Scholar]
  89. Ahmad I, Khan SB, Rehman H, Khan MH, Anwar S. Frequency of hepatitis B and hepatitis C among cataract patients. Gomal J Med Sci. 2006;4:61–64. [Google Scholar]
  90. Khokhar N, Alam AY, Naz F. Hepatitis B surface antigenemia in patients on hemodialysis. Rawal Med J. 2004;29:18–21. [Google Scholar]
  91. Mumtaz A, Salaria SM, Bukhari SH, Khan NS. Study of hepatitis 'B' antigenaemia in government hospital for psychiatric diseases. Ann King Edward Med Coll. 2002;8:167–8. [Google Scholar]
  92. Tayyab GN, Arfeen N, Ahmad U, Hafeez A. Seroprevalence of hepatitis B in patients suffering from hepatitis in Lahore, Pakistan. Pak J Gastroenterol. 1999;13:5–7. [Google Scholar]
  93. Mahboob A, Haroon TS, Iqbal Z, Saleemi MA, Munir A. Prevalence of hepatitis B surface antigen carrier state in patients with lichen planus - report of 200 cases from Lahore, Pakistan. J Ayub Med Coll Abottabad. 2007;19:68–70. [PubMed] [Google Scholar]
  94. Khan MS, Jamil M, Jan S, Zardad S, Sultan S, Sahibzada AS. Prevalence of hepatitis 'B' and 'C' in orthopaedics patients at Ayub teaching hospital Abbottabad. J Ayub Med Coll Abottabad. 2007;19:82–84. [PubMed] [Google Scholar]
  95. Price, Boxall. Treatment of children persistently infected with hepatitis B virus: seroconversion or suppression. J Antimicrob Chemother. 2007;60:1189–1192. doi: 10.1093/jac/dkm362. [DOI] [PubMed] [Google Scholar]
  96. Awan Z, Idrees M, Amin I, Butt S, Afzal S, Akbar H, Rehman IU, Younas S, Shahid M, Lal A, Saleem S, Rauff B. Pattern and molecular epidemiology of hepatitis B virus genotypes circulating in Pakistan. Infect Genet Evol. 2010;10:1242–6. doi: 10.1016/j.meegid.2010.08.006. [DOI] [PubMed] [Google Scholar]
  97. Ahmed CS, Wang ZH, Bin Z, Chen JJ, Kamal M, Hou JL. Hepatitis B virus genotypes, subgenotypes, precore, and basal core promoter mutations in the two largest provinces of Pakistan. J Gastroenterol Hepatol. 2009;24:569–73. doi: 10.1111/j.1440-1746.2008.05642.x. [DOI] [PubMed] [Google Scholar]
  98. Baig S, Siddiqui A, Chakravarty R, Moatter T. Hepatitis B virus subgenotypes D1 and D3 are prevalent in Pakistan. BMC Res Notes. 2009;2:1. doi: 10.1186/1756-0500-2-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Alam MM, Zaidi SZ, Malik SA, Shaukat S, Naeem A, Sharif S, Angez M, Butt JA. Molecular epidemiology of hepatitis B virus genotypes in Pakistan. BMC Infect Dis. 2007;7:115. doi: 10.1186/1471-2334-7-115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Baig S, Siddiqui AA, Ahmed W, Qureshi H, Arif A. The association of complex liver disorders with HBV genotypes prevalent in Pakistan. Virology J. 2007;4:128. doi: 10.1186/1743-422X-4-128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Abbas Z, Muzaffar R, Siddiqui A, Naqvi AA, Rizvi AH. Genetic variability in the precore and core promoter regions of hepatitis B virus strains in Karachi. BMC Gastroenterol. 2006;6:20. doi: 10.1186/1471-230X-6-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Khan A, Aqeel M, Tariq SM, Khattak AA. Frequency of hepatitis B surface antigen and its association with possible risk factors in hospitalized pediatric patients. Pak Paed J. 2009;3:39–43. [Google Scholar]
  103. Qureshi H, Arif A, Riaz K, Alam SE, Ahmed W, Mujeeb SA. Determination of risk factors for hepatitis B and C in male patients suffering from chronic hepatitis. BMC Res Notes. 2009;2:212. doi: 10.1186/1756-0500-2-212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Ahmad K. Pakistan: a cirrhotic state? The Lancet. 2004;364:1843–1844. doi: 10.1016/S0140-6736(04)17458-8. [DOI] [PubMed] [Google Scholar]
  105. Aziz S, Memon A, Tily HI, Rasheed K, Jehangir K, Quraishy MS. Prevalence of HIV, hepatitis B and C amongst health workers of civil hospital Karachi. J Pak Med Assoc. 2002;52:92–4. [PubMed] [Google Scholar]
  106. Janjua NZ, Nizamy MAM. Knowledge and practices of barbers about hepatitis B and C transmission in Rawalpindi and Islamabad. J Pak Med Assoc. 2004;54:116–9. [PubMed] [Google Scholar]
  107. Karan MA, Tascioglu C, Erten N, Ozturk AO, Palanduz S, Carin M. The role of HLA antigens in chronic hepatitis B virus infection. J Pak Med Assoc. 2002;52:253–6. [PubMed] [Google Scholar]
  108. Nasim S, Shahid A, Pirzada AG, Memon AA. Perception of adolescent females about viral hepatitis in urban and rural Sindh. Pak J Med Res. 2009;48:71–3. [Google Scholar]
  109. Haider G, Haider A. Awareness of women regarding hepatitis B. J Ayub Med Coll Abbottabad. 2008;20:141–144. [PubMed] [Google Scholar]
  110. Mengal H, Howteerakul N, Suwannapong N, Rajatanun T. Factors relating to acceptance of hepatitis B virus vaccination by nursing students in a tertiary hospital, Pakistan. J Health Popul Nutr. 2008;26:46–53. [PMC free article] [PubMed] [Google Scholar]
  111. Chaudhry MA, Rizvi F, Ashraf MZ, Afzal M, Niazi S. Knowledge and practices of barbers regarding hepatitis B and hepatitis C in Bahra Kahu, Islamabad-Pakistan. Rawal Med J. 2010;35:37–40. [Google Scholar]
  112. Waheed Y, Saeed U, Safi SZ, Chaudhry WN, Qadri I. Awareness and risk factors associated with barbers in transmission of hepatitis B and C from Pakistani population: barber's role in viral transmission. Asian Biomedicine. 2010;4:435–442. [Google Scholar]
  113. Ali A, Akhtar S, Saqi SK. Awareness of viral hepatitis among people of rural areas of Faisalabad, Pakistan. Pak J life Soc Sci. 2004;2:57–58. [Google Scholar]
  114. Asif SA, Iqbal R, Hussain H, Khan MH. Awareness of viral hepatitis in ten villages of district Nowshera. Gomal J Med Sci. 2009;7:10–13. [Google Scholar]
  115. Talpur AH, Memon NA, Solangi RA. Knowledge and attitude of patients towards hepatitis B and C. Pak J Surg. 2007;23:162–165. [Google Scholar]

Articles from Virology Journal are provided here courtesy of BMC

RESOURCES